Objective: We investigated whether determination IL-6, IL-8, IL-1beta and TNF-alpha at baseline, total protein C (PC) levels at time of admission and 48 hours after initiation could complement the Acute Physiology and Chronic Health Evaluation (APACHE) II scoring system to identify patients with sepsis, severe sepsis or septic shock for clinical outcome.
Introduction
Sepsis is defined as a systemic inflammatory response to infection associated with the activation of a number of host defense mechanisms including the cytokine network, leukocytes and the hemostatic system (1) . Proinflammatory cytokines activate the coagulation cascade via tissue factor, inhibit fibrinolysis, and cause a decrease in AT-III and PC, which are the anticoagulant proteins in plasma. The PC pathway also plays a significant role in inflammatory processes and improves the outcome of patients with sepsis (2) .
The current use of severity scores, such as the APACHE II or III scoring systems, use age, medical history and physiological determinants, including body temperature, blood pressure, and serum electrolyte concentrations to quantify the degree of physiologic derangement and to predict outcome (3, 4) .
The severity of sepsis is related to the intensity of the inflammatory host response. Excessive production of proinflammatory cytokines such as tumor necrosis factor (TNF)-a, interleukin (IL)1b, IL-6 and IL-8 by immunocompetent cells can induce the systemic inflammatory response syndrome (SIRS) and these cytokines play an important role in the development of acute respiratory syndrome or multiple organ dysfunction syndrome (5) (6) (7) .
This requires being able to show a correlation between the mediators and severity scores of the disease. Even though many studies associated with prognostic factors in sepsis are available to date, the correlation with severity scores of the disease is not very well known. We investigated whether determination IL-6, IL-8, IL-1beta and TNF-alpha at baseline, total protein C (PC) levels at time of admission and 48 hours after initiation could complement the APACHE II scoring system to identify patients with sepsis, severe sepsis or septic shock for clinical outcome.
Material and Methods
The prospective study was conducted at the university hospital. The study was approved by the institution's ethics committee.
Patients
Patients were included if they had clinical evidence of systemic inflammatory response syndrome due to infection and evidence of sustained hypotension or organ hypoperfusion as a result of SIRS. Sepsis and severe sepsis or septic shock were defined according to recent guidelines (8) .
The severity of each patient was evaluated on the basis of the APACHE II scoring system (1) .
Sixty patients were included in the study and were followed for 28 days or until death.
Exclusion criteria were age <18 years, pregnancy, use of cytokines, use of heparine or thrombolytic therapy, end-stage neoplasm or other diseases, history of transplantation, requiring hemodialysis or peritoneal dialysis, treatment for malignant hematological diseases, and patients not expected to survive 24 hours.
Demographics and Baseline Characteristics
At inclusion, demographic information regarding the patients (age, gender, underlying diseases such as infection with human immunodeficiency virus (HIV), malignancies or diabetes mellitus, prior treatment with immuncompromising (cytostatic or steroidal) drugs or antibiotics) were recorded. APACHE II scores were calculated. Routine hematologic, chemistry, and coagulation parameters were obtained at study entry and followed throughout. Coagulation assays were performed at study entry and followed daily during the initial five days. Data obtained at this time included platelet count, prothrombin time, partial thromboplastin time and fibrinogen levels. Diagnostic investigations of suspected foci of infection (e.g. cultures of blood and tissue) were done according to the decisions of the attending physician.
Blood Sampling Procedures
Venous blood samples for the determination of plasma levels of cytokines were obtained at the beginning of the study. In addition, venous blood samples for the determination of plasma levels of total PC were collected in vacutainer tubes containing EDTA at the beginning of the study and 48 hours after initiation. All samples were centrifuged at 3000 rpm for 10 minutes. Serum samples for cytokines levels and plasma samples for PC levels were stored immediately at -70 o C until processing.
Cytokines Assays
Plasma concentrations of IL-6, IL-8, IL-1b and TNF-a were measured with an enzyme-linked immunosorbant assay (ELISA, Research Diagnostic, BioSource International, Inc., immunoassay kit, California) according to manufacturer's conditions. The sensitivities of the assays were <2 pg/mL for IL-6, <5 pg/mL for IL-8, 1 pg/mL for IL-1 b, 1.7pg/mL for TNF-a respectively. The serum levels of these cytokines are below the detection limit in healthy subjects. Results were related to a dose-response curve obtained with recombinant human IL-6, IL-8, IL-1b and TNF-a and expressed as picograms per milliliter.
PC Antigen Assays
Total PC antigen levels in the heparinized plasma were measured with a commercially available antigen assay Asserachrom Protein C (Stago Diagnostica, Asniers, France) following the manufacturer's instructions. This sandwich-based ELI-SA uses rabbit antihuman PC F (ab) 2 fragments as the capture antibody. Dilutions in the ratio of 1/50 of plasma samples were made. The reference range is 70-140% in a normal adult. The reported range was 14.6-max %. Values of PC levels above the detection limit of assay (max %) were calculated logarithmically with respect to their optical densities.
Clinical Outcome
Patients were observed for clinical outcomes, with 28-day all case mortality as the primary outcome measure. The relationship among PC levels at baseline and after 48 hours, cytokines and APACHE II score to 28 -day all cause mortality, were investigated.
Statistical Analysis
Values of cytokine levels below the detection limit of assay were replaced by 0. Values of cytokine levels above the detection limit of assay were calculated logarithmically according to optical density. The distributions of all continuous variables for normal distribution were tested using the KolmogorovSmirnov test. The variables with normal distributions were compared between groups by the Student's t-test. MannWhitney U tests were applied for non-normally distributed variables. For normally distributed variables, mean and standard deviation were used, for non-normally distributed variables median and 25 th -75 th percentiles were used. Categorical variables were compared between groups with chi-square analysis. Correlations between variables were determined by using the Pearson correlation analysis for normally distributed variables, and by the Spearman correlation analysis for non-normally distributed variables. Forward multiple logistic regression analysis was used for PC 48 hours after initiation, baseline IL-levels and APACHE II score to predict mortality. The power of the study was calculated as 0.595.This power value was obtained using the SigmaStat 3.5 programme according to the APACHE II score with 60 sample size.
Results
We prospectively enrolled 60 patients meeting the criteria for sepsis (n=41), severe sepsis or septic shock (n=19). 24 patients were female and 36 male, with a mean age of 58±18.2 years. Infections were microbiologically proven in 39 of 60 infected patients (65%). 12% of septic patients and 58% of septic shock or severe sepsis had positive blood cultures. In total, 21 patients were deceased. The mean APACHE II score was 17.3. The APACHE II score, mean baseline IL-6 level and PC level at 48 hours after initiation were significanly higher in the severe sepsis or septic shock group than in the sepsis group (p=0.000, p=0.016 and p=0.044, respectively). The mean baseline IL-1 b, IL-8, TNF-a and PC did not differ between sepsis and severe sepsis or septic shock patients. The main patient characteristics, cytokine levels, PC levels baseline and 48 hours after initiation, APACHE II scores and mortality rates are shown in Table 1 .
Cytokine levels did not differ according to the source of infection. Cytokine levels also did not differ with positive blood culture results. Table 2 shows the focus of infection and causative organism and blood culture results.
The APACHE II score, baseline IL-6 level and PC level at 48 hours after initiation were significantly higher in deceased than in survivors (p=0.017, p=0.016 and p=0.049 respectively). Demographic data, cytokine levels, PC levels, and APACHE II scores of both surviving and deceased patients are shown in Table 3 .
In the present study, forward multiple logistic regression analysis were used for IL-6 levels, PC levels at baseline, 48 hours after initiation and APACHE II scores to predict mortality. Only the APACHE II score (OR: 1.098, p=0.022) was found to be an independent predictor for mortality of septic patients. In addition baseline IL-6 and PC levels 48 hours after initiation measurements did not reveal any predictive value of mortality in combination with the APACHE score tested (Figure 1) .
The correlation between the APACHE score and blood IL-6, IL-8, IL-1beta and TNF-alpha were analyzed. A significant positive correlation was observed between them except IL-1 b (p=0.002, p=0.007, p=0.851, p=0.018, and p=0.326 respectively) ( Table 4 ). The correlation between the APACHE score and PC baseline and 48 hours after initiation were also analyzed. No correlation between the APACHE score and PC levels (baseline and 48 hours after initiation) was detected. PC levels baseline and 48 hours after initiation were not associated with cytokines.
Despite the significant positive correlation between IL-6, IL-8, TNF-a and APACHE II scores, our multivariate analysis of these did not reveal any predictive value in combination with the APACHE II score.
Discussion
The interrelationships between endogenous mediators and their roles in the pathophysiology of systemic inflammation are extremely complex. Multiple mediators have been identified, both other proinflammatory mediators and antiinflammatory mediators (9, 10) . Proinflammatory cytokines activate the coagulation cascade via tissue factor, inhibit fibrinolysis, and cause a decrease in AT-III and PC, which are the anticoagulant proteins in plasma (11) .
Previous studies have shown that there was a similar positive correlation between the APACHE II score and blood IL-6 and TNF-a level on admission to ICU in patients with SIRS and sepsis (2, 12) . A significant correlation was found among initial serum levels of IL-6, IL-8, TNF-a and the APACHE II score in the present study as in previous studies (12) (13) (14) . In the study Table 3 . Demographic data, Cytokine levels, PC levels, APACHE II scores of surviving and deceased patients of Presterl et al., TNF-a was not found to be correlated with any scoring system, while IL-6 was found to be correlated with MPM II and APACHE III score on day 1 and 2 respectively. The authors suggested that IL-6 should be included in the assessment models of outcome prediction patients with sepsis, either associated with or included in a clinical scoring system (14, 15) . In addition, Dhainaut et al. reported that the predictive power of APACHE II plus IL-6 was higher with respect to the predictive value of the APACHE II alone (13). Oberholzer and colleagues investigated the relationship of several cytokine and physiological scoring systems for predicting the clinical outcome in patients with severe sepsis. They have demonsrated that, of the cytokines examined, only baseline IL-6 and TNF receptor concentrations (TNF-R1) discriminated among patients who survived or died, and only IL-6 concentrations remained significant when combined with age and the baseline APACHE II and MOD scores (14) (15) (16) . A significant correlation of initial serum levels of TNF-a, IL-6 and other cytokines and the APACHE II scores in 13 patients with meningoccocal and pneumococcal septic shock was reported (12) . Recently Uras and colleagues have reported that for serum CRP and IL-6 levels there was no significant difference between neonatal bacterial sepsis and transient tachypnea of newborn (17) . This study suggests that IL-6, IL-8 and TNF-a baseline levels correlate with the severity of the physiologic insult, as determined by the APACHE II score. However, our multivariate analysis of these did not reveal any predictive value in combination with the APACHE II score. The normal range of circulating levels of PC has been established by several studies and varies over approximately a two-fold range between the upper and lower limits (70%-140%) (18) (19) (20) . Numerous studies have shown that acquired PC deficiency is prevalent in the majority of septic patients and is associated with increased morbidity and mortality (21) (22) (23) . In the present study, only PC levels 48 hours after initiation in patients who died were below the lower limit. PC levels 48 hours after initiation were found to be a prognostic marker for a fatal clinical outcome. However, our results showed no correlation between total PC concentrations 48 hours after initiation and APACHE II score. In this study, total PC concentration did not offer any predictive advantage over the APACHE II score alone in septic shock patients, as in the study of Oberholzer and colleagues (14) .
In recent years, activation of the cytokine cascade and subsequent coagulation abnormalities has begun to attract close attention as a possible factor responsible for multiple organ dysfunction (24) . The effectiveness of recombinant human activated PC against severe sepsis has been demonstrated in a multi-center study (25) . These findings suggest that sequential monitoring of blood IL-6 levels allows a precise prediction of activation of the coagulation system induced by cytokine activation and subsequent onset of organ dysfunction, thus enabling anti-coagulant therapy and anti-cytokine therapy to be carried out with optimum timing (5) . Our data suggests that there are prognostic values of baseline blood IL-6 levels and PC levels 48 hours after initiation in patients with sepsis, and severe sepsis or septic shock at an early stage. Baseline IL 6 levels and PC levels 48 hours after initiation showed no correlation.
Conclusion
In this prospective evaluation of several different sepsis indicators in a consecutive series of patients, the APACHE II score proved to be the best indicator of sepsis in newly admitted critically ill patients. Although determination of baseline IL-6 and total PC concentrations at 48 hours after initiation have a prognostic value for the outcome of septic patients, this did not significantly increase the predictive power of the APACHE scoring system to identify patients with sepsis for a fatal clinical outcome. Future studies need to evaluate these approaches in patients with sepsis. 
